R

Ring Therapeutics

Programmable genetic medicines via viral delivery

Scientist 1 - Analytical Development

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
ContractCambridge, MA, USA$48 - $62 /hr

About the Job

Requirements

  • A Ph.D. in Biology, Biochemistry, Bioengineering, or a related field with 0–2 years of industry experience, or an M.S. with 7+ years of relevant industry experience.
  • Strong background in protein science and demonstrated ability to independently develop, optimize, and troubleshoot analytical assays.
  • Broad hands-on experience with protein characterization techniques and analytical instrumentation.
  • Strong attention to detail and scientific problem-solving skills.
  • Ability to manage multiple priorities and adapt to changing needs in a dynamic environment.
  • Effective written and verbal communication skills.

Responsibilities

  • Perform hands-on analytical testing using chromatography methods including SEC, HIC, IEX, and RPC; MALS; capillary electrophoresis methods including cIEF, CZE, and CE-SDS; and other advanced technologies.
  • Develop, optimize, and troubleshoot analytical methods for characterizing proteins, conjugated biologics, and related modalities.
  • Support analytical characterization of VDCs (Vector Drug Conjugates), VOCs (Vector Oligo Conjugates), and other conjugated biologics, including payload-related analytics using HPLC and capillary electrophoresis-based methods.
  • Characterize critical quality attributes such as purity, aggregation, size, and charge variants.
  • Perform sample preparation, assay setup, and analytical data analysis for routine analytical workflows.

Desired Qualifications

  • Experience with CE-SDS using capillary electrophoresis platforms such as Maurice, ProteinSimple, or PA800 Plus/SCIEX.
  • Experience with an Orbitrap Exploris 240 Mass Spectrometer.
  • Experience with automated Western blot systems such as Jess/ProteinSimple and Western blot.
  • Exposure to biologics analytical development environments.

About the Company

Ring Therapeutics

Programmable genetic medicines via viral delivery

Ring Therapeutics develops programmable genetic medicines using a commensal virus platform called Anellogy to create viral-based therapies that can safely deliver treatments to targeted cells and tissues. How it works: engineered anelloviruses are used as delivery vehicles, carrying diverse therapeutic payloads to specific tissues, leveraging their long-evolved ability to evade the immune system and their presence across many tissues. How it differs: instead of traditional viral vectors, Ring leverages a natural, tissue-spreading family of viruses (anelloviruses) with broad tissue tropism and a platform designed for multiple payloads, enabling potentially customizable and repeatable therapies. Goal: to develop and commercialize these programmable genetic medicines to treat patients with significant medical needs, advancing a platform that could enable multiple therapeutic modalities across different tissues.

Company size
11-50
Company stage
Series C
Total funding
$253.5M
Headquarters
Cambridge, MA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Ring Therapeutics

See more jobs